GSKN.MX GlaxoSmithKline plc

Healthcare Pharmaceuticals Mexican Exchange
960.00 MXN
Close of Nov 7, 2026
836.19 1,022
Market cap
MXN 1.92T
P/E
19.0x
P/B
4.00x
ROE
26.4%
Dividend yield
3.36%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is GSKN.MX undervalued?

Graham number
Price960.00
Graham value522.89
Premium83.6%

GSKN.MX trades 83.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

GlaxoSmithKline plc fundamental analysis

No fundamental analysis for GlaxoSmithKline plc yet.

GlaxoSmithKline plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About GlaxoSmithKline plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, …

Full company profile